Fortis Capital Advisors LLC bought a new position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,622 shares of the company's stock, valued at approximately $276,000.
Other large investors have also bought and sold shares of the company. Focus Partners Wealth grew its stake in shares of Procter & Gamble by 8.9% during the 1st quarter. Focus Partners Wealth now owns 1,782,391 shares of the company's stock worth $303,755,000 after acquiring an additional 145,344 shares in the last quarter. Strive Asset Management LLC grew its stake in shares of Procter & Gamble by 3.5% during the 1st quarter. Strive Asset Management LLC now owns 4,053 shares of the company's stock worth $691,000 after acquiring an additional 136 shares in the last quarter. Integrity Alliance LLC. grew its stake in shares of Procter & Gamble by 229.1% during the 1st quarter. Integrity Alliance LLC. now owns 42,628 shares of the company's stock worth $7,265,000 after acquiring an additional 29,676 shares in the last quarter. Ransom Advisory Ltd bought a new position in shares of Procter & Gamble during the 1st quarter worth approximately $3,678,000. Finally, Aspen Investment Management Inc grew its stake in shares of Procter & Gamble by 2.1% during the 1st quarter. Aspen Investment Management Inc now owns 7,507 shares of the company's stock worth $1,279,000 after acquiring an additional 153 shares in the last quarter. 65.77% of the stock is owned by institutional investors.
Procter & Gamble Trading Down 1.2%
Shares of Procter & Gamble stock opened at $157.49 on Thursday. The business has a fifty day simple moving average of $156.30 and a two-hundred day simple moving average of $162.09. Procter & Gamble Company has a 1 year low of $149.91 and a 1 year high of $180.43. The company has a market capitalization of $368.59 billion, a price-to-earnings ratio of 24.19, a P/E/G ratio of 4.21 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter last year, the firm posted $1.40 EPS. The company's quarterly revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were issued a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 annualized dividend and a yield of 2.7%. Procter & Gamble's dividend payout ratio (DPR) is currently 64.98%.
Wall Street Analyst Weigh In
Several equities analysts have recently weighed in on the stock. UBS Group set a $180.00 price target on shares of Procter & Gamble and gave the stock a "buy" rating in a research note on Wednesday, July 30th. Evercore ISI reissued an "in-line" rating and issued a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $170.00 price objective (down previously from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. Wells Fargo & Company cut their price objective on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Finally, Barclays set a $164.00 price objective on Procter & Gamble and gave the company an "equal weight" rating in a report on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $175.12.
View Our Latest Stock Analysis on Procter & Gamble
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, CEO Jennifer L. Davis sold 8,596 shares of the firm's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,351,892.92. Following the completion of the sale, the chief executive officer owned 64,991 shares of the company's stock, valued at $10,221,134.57. This trade represents a 11.68% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Ma. Fatima Francisco sold 9,100 shares of the firm's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,431,157.00. Following the sale, the chief executive officer directly owned 27,295 shares of the company's stock, valued at $4,292,684.65. This represents a 25.00% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 120,181 shares of company stock worth $18,918,012. 0.20% of the stock is currently owned by corporate insiders.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report